Experimental Alzheimer’s drug gets FDA advisory panel’s thumbs-up: ‘Progress is happening’

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel on Monday. Industry experts and doctors shared reactions. Read More in FOX News.   Read More in Red Pill NOWlej.